Skip to main content
. Author manuscript; available in PMC: 2016 Oct 24.
Published in final edited form as: Br J Haematol. 2015 Apr 7;170(1):85–95. doi: 10.1111/bjh.13399

Fig 1.

Fig 1

(A) PFS for FL patients aged >80 years in the NLCS based on their initial treatment strategy. No specific regimen amongst these studied provided these elderly patients with a superior PFS.

(B) PFS for FL patients aged >80 years in the NLCS based on anthracycline use. Anthracyclines did not improve PFS in this elderly cohort.

(C) OS for patients aged >80 years based on initial treatment selection. No particular regimen improved OS in this elderly cohort.

(D) OS for patients aged >80 years based on anthracycline use. Anthracyclines did not improve OS in this elderly cohort.

FL, follicular lymphoma; NLCS, National LymphoCare Study; OS, overall survival; PFS, progression-free survival